Q32 Bio Inc. (QTTB)

Q32 Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.35	1.16	3.21	33.97	2.7	1.67
Revenue Growth (YoY)	-93.39%	-63.97%	-90.56%	1157.25%	62.18%	-68.70%
Gross Profit	0.35	1.16	3.21	33.97	2.7	1.67
Selling, General & Admin	27.93	31.26	38.14	36.84	32.57	22.21
Research & Development	51.86	62	98.35	93.09	100.39	89.4
Other Operating Expenses	9.33	9.33	0	0	0	0
Operating Expenses	89.12	102.59	136.49	129.92	132.97	111.61
Operating Income	-88.76	-101.43	-133.28	-95.95	-130.26	-109.94
Other Expense / Income	-5.67	11.53	-128.99	-0.19	-1.57	-6.03
Pretax Income	-83.09	-112.96	-4.29	-95.76	-128.69	-103.92
Income Tax	0	0	0.72	0	0	0
Net Income	-83.09	-112.96	-5.01	-95.76	-128.69	-103.92
Shares Outstanding (Basic)	1	3	3	3	3	2
Shares Outstanding (Diluted)	2	3	3	3	3	2
Shares Change	577.31%	0.76%	3.83%	20.41%	9.01%	47.51%
EPS (Basic)	-25.07	-35.10	-1.62	-31.14	-50.40	-44.46
EPS (Diluted)	-32.43	-35.10	-1.62	-31.14	-50.40	-44.46
Free Cash Flow	-84.17	-95.9	-114.95	-112.15	-98.07	-113.19
Free Cash Flow Per Share	-84.57	-29.85	-36.05	-36.52	-38.45	-48.38
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-25073.73%	-8774.13%	-4154.64%	-282.44%	-4820.98%	-6599.22%
Profit Margin	-23471.19%	-9771.71%	-156.02%	-281.90%	-4762.92%	-6237.45%
Free Cash Flow Margin	-23777.68%	-8296.19%	-3583.10%	-330.13%	-3629.35%	-6794.18%
EBITDA	-80.77	-110.32	-1.69	-86.22	-119.79	-97.6
EBITDA Margin	-22815.82%	-9543.08%	-52.71%	-253.80%	-4433.38%	-5858.22%
Depreciation & Amortization	2.32	2.64	2.6	9.54	8.9	6.32
EBIT	-83.09	-112.96	-4.29	-95.76	-128.69	-103.92
EBIT Margin	-23471.19%	-9771.71%	-133.73%	-281.90%	-4762.92%	-6237.45%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).